FIELD: medicine.
SUBSTANCE: physiotherapeutic goggle device BLEPHASTEAM is placed over an orbital cavity. Restasis is applied on cotton pads in the amount of 4 drops equally spaced over each cotton pad. The pads are placed into the device. The physiotherapeutic exposure covers open eyelids for 10 minutes daily. The therapeutic course consists of 20 sessions.
EFFECT: method provides a pronounced anti-inflammatory, reparative, anti-allergic effect with reducing the length of treatment and ensuring cost advantages of using the expensive drug Restasis evaporated in the goggle BLEPHASTEAM, allowing for the simultaneous effect on the cornea, conjunctiva and eyelids.
8 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF HEAVY FORMS OF DRY KERATOCONJUNCTIVITIS | 2016 |
|
RU2621553C1 |
| METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
| METHOD OF TREATING BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2510701C1 |
| METHOD FOR DRY EYE SYNDROME TREATMENT IN PATIENTS WITH DIABETES MELLITUS | 2020 |
|
RU2749984C1 |
| METHOD OF "DRY EYE" SYNDROME TREATMENT | 2014 |
|
RU2546922C1 |
| PHARMACEUTICAL COMPOSITION FOR INTEGRATED TREATMENT OF OCULAR SURFACE DISEASES IN PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA | 2011 |
|
RU2460517C1 |
| COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2011 |
|
RU2464985C1 |
| COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2013 |
|
RU2517033C1 |
| COMPOSITION FOR HYGIENIC TREATMENT OF THE EYELIDS | 2021 |
|
RU2778503C1 |
| METHOD FOR ASSESSING MORPHOFUNCTIONAL STATUS OF MEIBOMIAN GLANDS - MEIBOMIAN GLANDS BIOMETRY | 2014 |
|
RU2567829C1 |
